Schonfeld Strategic Advisors’s Accendra Health ACH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-44,283	Closed	-$124K	–	2539
2025 Q4	$124K	Sell	44,283 -96,748	-69%	-$346K	﹤0.01%	1788
2025 Q3	$677K	Buy	+141,031	New	+$897K	﹤0.01%	1550
2024 Q3	–	Sell	-55,815	Closed	-$754K	–	2315
2024 Q2	$754K	Buy	+55,815	New	+$1.14M	﹤0.01%	1323
2023 Q2	–	Sell	-33,700	Closed	-$490K	–	2395
2023 Q1	$490K	Buy	33,700 +6,274	+23%	+$112K	﹤0.01%	1175
2022 Q4	$536K	Buy	+27,426	New	+$535K	﹤0.01%	1492
2021 Q4	–	Sell	-10,135	Closed	-$317K	–	2422
2021 Q3	$317K	Buy	+10,135	New	+$399K	﹤0.01%	1499
2018 Q1	–	Sell	-10,855	Closed	-$205K	–	921
2017 Q4	$205K	Buy	+10,855	New	+$241K	0.02%	668
2017 Q3	–	Sell	-62,231	Closed	-$2M	–	732
2017 Q2	$2M	Buy	62,231 +42,821	+221%	+$1.41M	0.21%	148
2017 Q1	$671K	Sell	19,410 -2,572	-12%	-$91.8K	0.07%	319
2016 Q4	$776K	Buy	+21,982	New	+$743K	0.1%	264

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schonfeld Strategic Advisors's ACH Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 44,283 shares — an estimated $124K sold.

Schonfeld Strategic Advisors first reported a position in ACH in Q4 2016 and held it in 10 quarters. The position peaked at $2M in Q2 2017. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Schonfeld Strategic Advisors reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 44,283 Accendra Health shares in Q1 2026, an estimated $124K.
Schonfeld Strategic Advisors first reported a position in Accendra Health in Q4 2016 and held it in 10 quarters.
Schonfeld Strategic Advisors's Accendra Health position peaked at $2M in Q2 2017.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.